CLINICAL STUDIES
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
Donald S. Silverberg, MDa,
Dov Wexler, MDa,
Miriam Blum, MDa,
Gad Keren, MDa,
David Sheps, MDa,
Eyal Leibovitch, MDa,
David Brosh, MDa,
Shlomo Laniado, MDa,
Doron Schwartz, MDa,
Tatyana Yachnin, MDa,
Itzhak Shapira, MDa,
Dov Gavish, MDa,
Ron Baruch, MDa,
Bella Koifman, MDa,
Carl Kaplan, MDa,
Shoshana Steinbruch, RNa and
Adrian Iaina, MDa
a Department of Nephrology and Cardiology, and Congestive Heart Failure Program, Tel Aviv Medical Center, Tel Aviv, Israel
Manuscript received July 9, 1999;
revised manuscript received December 10, 1999,
accepted February 3, 2000.
Reprint requests and correspondence: Dr. D. S. Silverberg, Department of Nephrology, Tel Aviv Medical Center, Weizman 6, Tel Aviv, 64239, Israel
OBJECTIVES
This study evaluated the prevalence and severity of anemia in patients with congestive heart failure (CHF) and the effect of its correction on cardiac and renal function and hospitalization.
BACKGROUND
The prevalence and significance of mild anemia in patients with CHF is uncertain, and the role of erythropoietin with intravenous iron supplementation in treating this anemia is unknown.
METHODS
In a retrospective study, the records of the 142 patients in our CHF clinic were reviewed to find the prevalence and severity of anemia (hemoglobin [Hb] <12 g). In an intervention study, 26 of these patients, despite maximally tolerated therapy of CHF for at least six months, still had had severe CHF and were also anemic. They were treated with subcutaneous erythropoietin and intravenous iron sufficient to increase the Hb to 12 g%. The doses of the CHF medications, except for diuretics, were not changed during the intervention period.
RESULTS
The prevalence of anemia in the 142 patients increased with the severity of CHF, reaching 79.1% in those with New York Heart Association class IV. In the intervention study, the anemia of the 26 patients was treated for a mean of 7.2 ± 5.5 months. The mean Hb level and mean left ventricular ejection fraction increased significantly. The mean number of hospitalizations fell by 91.9% compared with a similar period before the study. The New York Heart Association class fell significantly, as did the doses of oral and intravenous furosemide. The rate of fall of the glomerular filtration rate slowed with the treatment.
CONCLUSIONS
Anemia is very common in CHF and its successful treatment is associated with a significant improvement in cardiac function, functional class, renal function and in a marked fall in the need for diuretics and hospitalization.
|
Abbreviations and Acronyms
| | ACE | = angiotensin-converting enzyme | | CHF | = congestive heart failure | | COPD | = chronic obstructive pulmonary disease | | CRF | = chronic renal failure | | CVA | = cerebrovascular accident | | EPO | = erythropoietin | | Fe | = iron | | g% | = grams Hb per 100 ml blood | | GFR | = glomerular filtration rate | | Hb | = hemoglobin | | Hct | = hematocrit | | IV | = intravenous | | LVEF | = left ventricular ejection fraction | | LVH | = left ventricular hypertrophy | | NYHA | = New York Heart Association | | %Fe Sat | = percent iron saturation | | SC | = subcutaneous | | TNF | = tumor necrosis factor |
|
This article has been cited by other articles:
|
|
|
|
 
K. Dimopoulos, G.-P. Diller, G. Giannakoulas, R. Petraco, A. Chamaidi, E. Karaoli, M. Mullen, L. Swan, M. F. Piepoli, P. A. Poole-Wilson, et al.
Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome.
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
2093 - 2100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Pergola, G. Gartenberg, M. Fu, M. Wolfson, S. Rao, and P. Bowers
A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
Clin. J. Am. Soc. Nephrol.,
November 1, 2009;
4(11):
1731 - 1740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J.V. McMurray, I. S. Anand, R. Diaz, A. P. Maggioni, C. O'Connor, M. A. Pfeffer, K. R. Polu, S. D. Solomon, Y. Sun, K. Swedberg, et al.
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
Eur J Heart Fail,
August 1, 2009;
11(8):
795 - 801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H.M. van Straten, M. A. Soliman Hamad, A. J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf
Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting: A Comparison With the Matched General Population
Circulation,
July 14, 2009;
120(2):
118 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
e1 - e90.
[Full Text]
[PDF]
|
|
|
|
|
|
|
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation,
April 14, 2009;
119(14):
e391 - e479.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Krikorian
Managing Anemia of Chronic Kidney Disease
American Journal of Lifestyle Medicine,
March 1, 2009;
3(2):
135 - 146.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Kazory and E. A. Ross
Anemia: the point of convergence or divergence for kidney disease and heart failure?
J. Am. Coll. Cardiol.,
February 24, 2009;
53(8):
639 - 647.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. Pagourelias, C. Koumaras, A. I. Kakafika, K. Tziomalos, P. G. Zorou, V. G. Athyros, and A. Karagiannis
Cardiorenal Anemia Syndrome: Do Erythropoietin and Iron Therapy Have a Place in the Treatment of Heart Failure?
Angiology,
February 1, 2009;
60(1):
74 - 81.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. S. Silverberg, D. Wexler, A. Iaina, and D. Schwartz
The Role of Correction of Anemia in Patients With Congestive Heart Failure Associated with Chronic Kidney Failure
Journal of Pharmacy Practice,
December 1, 2008;
21(6):
420 - 423.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Rastogi, M. Imai, V. G. Sharov, S. Mishra, and H. N. Sabbah
Darbepoetin-{alpha} prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2475 - H2482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo
Cardiorenal Syndrome
J. Am. Coll. Cardiol.,
November 4, 2008;
52(19):
1527 - 1539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Adlbrecht, S. Kommata, M. Hulsmann, T. Szekeres, C. Bieglmayer, G. Strunk, G. Karanikas, R. Berger, D. Mortl, K. Kletter, et al.
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume
Eur. Heart J.,
October 1, 2008;
29(19):
2343 - 2350.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Silverberg, D. Wexlerb, A. Iaina, and D. Schwartz
The role of correction of anaemia in patients with congestive heart failure: A short review
Eur J Heart Fail,
September 1, 2008;
10(9):
819 - 823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Anand
Anemia and Chronic Heart Failure: Implications and Treatment Options
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
501 - 511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. van der Meer, D. J. Lok, J. L. Januzzi, P. W. B.-A. de la Porte, E. Lipsic, J. van Wijngaarden, A. A. Voors, W. H. van Gilst, and D. J. van Veldhuisen
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients
Eur. Heart J.,
June 2, 2008;
29(12):
1510 - 1515.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Ghali, I. S. Anand, W. T. Abraham, G. C. Fonarow, B. Greenberg, H. Krum, B. M. Massie, S. M. Wasserman, M.-L. Trotman, Y. Sun, et al.
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
Circulation,
January 29, 2008;
117(4):
526 - 535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. O. Okonko, A. Grzeslo, T. Witkowski, A. K.J. Mandal, R. M. Slater, M. Roughton, G. Foldes, T. Thum, J. Majda, W. Banasiak, et al.
Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency: FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial
J. Am. Coll. Cardiol.,
January 15, 2008;
51(2):
103 - 112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Toblli, A. Lombrana, P. Duarte, and F. Di Gennaro
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1657 - 1665.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Francis and A. Kanderian
Anemia and Heart Failure: A New Pathway?
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1666 - 1667.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Desai, K. Bibbins-Domingo, M. G. Shlipak, A. H.B. Wu, S. Ali, and M. A. Whooley
Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): Findings from the Heart and Soul Study
Eur J Heart Fail,
September 1, 2007;
9(9):
886 - 891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Schwenger, C. Morath, and M. Zeier
Use of Erythropoietin after solid organ transplantation
Nephrol. Dial. Transplant.,
September 1, 2007;
22(suppl_8):
viii47 - viii49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hogenhuis, A. A. Voors, T. Jaarsma, A. W. Hoes, H. L. Hillege, J. A. Kragten, and D. J. van Veldhuisen
Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure
Eur J Heart Fail,
August 1, 2007;
9(8):
787 - 794.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Asaumi, Y. Kagaya, M. Takeda, N. Yamaguchi, H. Tada, K. Ito, J. Ohta, T. Shiroto, K. Shirato, N. Minegishi, et al.
Protective Role of Endogenous Erythropoietin System in Nonhematopoietic Cells Against Pressure Overload-Induced Left Ventricular Dysfunction in Mice
Circulation,
April 17, 2007;
115(15):
2022 - 2032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa
Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice
Circ. Res.,
March 16, 2007;
100(5):
662 - 669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ponikowski, S. D. Anker, J. Szachniewicz, D. Okonko, M. Ledwidge, R. Zymlinski, E. Ryan, S. M. Wasserman, N. Baker, D. Rosser, et al.
Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial
J. Am. Coll. Cardiol.,
February 20, 2007;
49(7):
753 - 762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Nanas, C. Matsouka, D. Karageorgopoulos, A. Leonti, E. Tsolakis, S. G. Drakos, E. P. Tsagalou, G. D. Maroulidis, G. P. Alexopoulos, J. E. Kanakakis, et al.
Etiology of Anemia in Patients With Advanced Heart Failure
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2485 - 2489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Falk, K. Swedberg, F. Gaston-Johansson, and I. Ekman
Fatigue and anaemia in patients with chronic heart failure
Eur J Heart Fail,
November 1, 2006;
8(7):
744 - 749.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F932 - F944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Valeur, O. W. Nielsen, J. J.V. McMurray, C. Torp-Pedersen, L. Kober, and TRACE Study Group
Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction
Eur J Heart Fail,
October 1, 2006;
8(6):
577 - 584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Norris, T. Greene, J. Kopple, J. Lea, J. Lewis, M. Lipkowitz, P. Miller, A. Richardson, S. Rostand, X. Wang, et al.
Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2928 - 2936.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Ripamonti, V. Racca, M. G. Calvo, P. Castiglioni, and M. Ferratini
Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery.
Chest,
July 1, 2006;
130(1):
79 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Go, J. Yang, L. M. Ackerson, K. Lepper, S. Robbins, B. M. Massie, and M. G. Shlipak
Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study
Circulation,
June 13, 2006;
113(23):
2713 - 2723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Grigorian Shamagian, A Varela Roman, J M Garcia-Acuna, P Mazon Ramos, A Virgos Lamela, and J R Gonzalez-Juanatey
Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function
Heart,
June 1, 2006;
92(6):
780 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-D. Tang and S. D. Katz
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Circulation,
May 23, 2006;
113(20):
2454 - 2461.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Satoh, Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, et al.
Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in Mice
Circulation,
March 21, 2006;
113(11):
1442 - 1450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum
Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes
Clin. J. Am. Soc. Nephrol.,
March 1, 2006;
1(2):
193 - 208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. O'Meara, T. Clayton, M. B. McEntegart, J. J.V. McMurray, C. C. Lang, S. D. Roger, J. B. Young, S. D. Solomon, C. B. Granger, J. Ostergren, et al.
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Circulation,
February 21, 2006;
113(7):
986 - 994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Similowski, A. Agusti, W. MacNee, and B. Schonhofer
The potential impact of anaemia of chronic disease in COPD
Eur. Respir. J.,
February 1, 2006;
27(2):
390 - 396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Opasich, M. Cazzola, L. Scelsi, S. De Feo, E. Bosimini, R. Lagioia, O. Febo, R. Ferrari, A. Fucili, R. Moratti, et al.
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
Eur. Heart J.,
November 1, 2005;
26(21):
2232 - 2237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Clark and J. G.F. Cleland
Anemia and Chronic Heart Failure: Are We Asking the Right Questions?
Circulation,
September 20, 2005;
112(12):
1681 - 1683.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hobson, P. A. Kalra, and P. R. Kalra
Cardiology and nephrology: time for a more integrated approach to patient care?
Eur. Heart J.,
August 2, 2005;
26(16):
1576 - 1578.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, A. L. Clark, P. Velavan, and L. Ingle
Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA
Eur J Heart Fail,
August 1, 2005;
7(5):
937 - 939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Felker, W. A. Gattis, K. F. Adams, and C. M. O'Connor
Reply
J. Am. Coll. Cardiol.,
May 3, 2005;
45(9):
1550 - 1551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. O. Cheng
Is There an Optimal Hematocrit Value for Cardiac Patients?
J. Am. Coll. Cardiol.,
May 3, 2005;
45(9):
1549 - 1549.
[Full Text]
|
|
|
|
|
|
|
S. Philipp, H. Ollmann, T. Schink, R. Dietz, F. C. Luft, and R. Willenbrock
The impact of anaemia and kidney function in congestive heart failure and preserved systolic function
Nephrol. Dial. Transplant.,
May 1, 2005;
20(5):
915 - 919.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Dahlstrom
Frequent non-cardiac comorbidities in patients with chronic heart failure
Eur J Heart Fail,
March 16, 2005;
7(3):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Caiola and J. W. Cheng
Use of Erythropoietin in Heart Failure Management
Ann. Pharmacother.,
December 1, 2004;
38(12):
2145 - 2149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.M. Felker, K. F. Adams Jr, W. A. Gattis, and C. M. O'Connor
Anemia as a risk factor and therapeutic target in heart failure
J. Am. Coll. Cardiol.,
September 1, 2004;
44(5):
959 - 966.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Shibagaki and A. Shetty
Anaemia is common after kidney transplantation, especially among African Americans
Nephrol. Dial. Transplant.,
September 1, 2004;
19(9):
2368 - 2373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A J S Coats
Anaemia and heart failure
Heart,
September 1, 2004;
90(9):
977 - 979.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. van der Meer, A. A. Voors, E. Lipsic, T. D. J. Smilde, W. H. van Gilst, and D. J. van Veldhuisen
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure
J. Am. Coll. Cardiol.,
July 7, 2004;
44(1):
63 - 67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Sharma, D. P Francis, B. Pitt, P. A Poole-Wilson, A. J.S Coats, and S. D Anker
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial
Eur. Heart J.,
June 2, 2004;
25(12):
1021 - 1028.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Silverberg, D. Wexler, M. Blum, D. Schwartz, and A. Iaina
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure
Nephrol. Dial. Transplant.,
April 1, 2004;
19(4):
1021 - 1021.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Henry, P. Bowers, M. T. Romano, and R. Provenzano
Epoetin Alfa: Clinical Evolution of a Pleiotropic Cytokine
Arch Intern Med,
February 9, 2004;
164(3):
262 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. van der Meer, A. A. Voors, E. Lipsic, W. H. van Gilst, and D. J. van Veldhuisen
Erythropoietin in cardiovascular diseases
Eur. Heart J.,
February 2, 2004;
25(4):
285 - 291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. H. Bahlmann, K. de Groot, J.-M. Spandau, A. L. Landry, B. Hertel, T. Duckert, S. M. Boehm, J. Menne, H. Haller, and D. Fliser
Erythropoietin regulates endothelial progenitor cells
Blood,
February 1, 2004;
103(3):
921 - 926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane
The cardiovascular effects of erythropoietin
Cardiovasc Res,
September 1, 2003;
59(3):
538 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Schroecksnadel, B. Wirleitner, D. Fuchs, W. Steinborn, P. Ponikowski, S. Anker, P. van der Meer, W. H. van Gilst, D. J. van Veldhuisen, J. Ezekowitz, et al.
Anemia and Congestive Heart Failure * Response
Circulation,
August 12, 2003;
108
(6):
e41 - e42.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Mozaffarian, R. Nye, and W. C. Levy
Anemia predicts mortality in severe heart failure: The prospective randomized amlodipine survival evaluation (PRAISE)
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
1933 - 1939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Silverberg
Outcomes of anaemia management in renal insufficiency and cardiac disease
Nephrol. Dial. Transplant.,
June 1, 2003;
18(suppl_2):
ii7 - ii12.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Ezekowitz, F. A. McAlister, and P. W. Armstrong
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure
Circulation,
January 21, 2003;
107(2):
223 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-S. Androne, S. D. Katz, L. Lund, J. LaManca, A. Hudaihed, K. Hryniewicz, and D. M. Mancini
Hemodilution Is Common in Patients With Advanced Heart Failure
Circulation,
January 21, 2003;
107(2):
226 - 229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Mancini, S. D. Katz, C. C. Lang, J. LaManca, A. Hudaihed, and A.-S. Androne
Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure
Circulation,
January 21, 2003;
107(2):
294 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Silverberg, D. Wexler, M. Blum, J. Z. Tchebiner, D. Sheps, G. Keren, D. Schwartz, R. Baruch, T. Yachnin, M. Shaked, et al.
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
Nephrol. Dial. Transplant.,
January 1, 2003;
18(1):
141 - 146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Parsi and F. X. Kleber
Anaemia in heart failure: its diagnosis and management
Eur J Heart Fail,
January 1, 2003;
5(1):
3 - 4.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Q. Hudson and K. S. Schonder
Advances in Anemia Management in Chronic Kidney Disease
Journal of Pharmacy Practice,
December 1, 2002;
15(6):
437 - 455.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. S. Silverberg, D. Wexler, and A. Iaina
The importance of anemia and its correction in the management of severe congestive heart failure
Eur J Heart Fail,
December 1, 2002;
4(6):
681 - 686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. M. McClellan, W. D. Flanders, R. D. Langston, C. Jurkovitz, and R. Presley
Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals: A Population-Based Study
J. Am. Soc. Nephrol.,
July 1, 2002;
13(7):
1928 - 1936.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. B. Horwich, G. C. Fonarow, M. A. Hamilton, W. R. MacLellan, and J. Borenstein
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1780 - 1786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N Cromie, C Lee, and A D Struthers
Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?
Heart,
April 1, 2002;
87(4):
377 - 378.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Maxwell, H. Y. Ong, and D. P. Nicholls
Influence of progressive renal dysfunction in chronic heart failure
Eur J Heart Fail,
March 1, 2002;
4(2):
125 - 130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-C. Wu, S. S. Rathore, Y. Wang, M. J. Radford, and H. M. Krumholz
Blood Transfusion in Elderly Patients with Acute Myocardial Infarction
N. Engl. J. Med.,
October 25, 2001;
345(17):
1230 - 1236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Al-Ahmad, W. M. Rand, G. Manjunath, M. A. Konstam, D. N. Salem, A. S. Levey, and M. J. Sarnak
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
955 - 962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-U. Eckardt
After 15 years of success--perspectives of erythropoietin therapy
Nephrol. Dial. Transplant.,
September 1, 2001;
16(9):
1745 - 1749.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira, et al.
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
J. Am. Coll. Cardiol.,
June 1, 2001;
37(7):
1775 - 1780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. O'Riordan and R. N. Foley
When should we start erythropoietin therapy?
Nephrol. Dial. Transplant.,
May 1, 2001;
16(5):
891 - 892.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Schunkert and H.-W. Hense
A heart price to pay for anaemia
Nephrol. Dial. Transplant.,
March 1, 2001;
16(3):
445 - 448.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Chatterjee, U. E. Nydegger, and P. Mohacsi
Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT1 antagonists
Eur J Heart Fail,
December 1, 2000;
2(4):
393 - 398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Erythropoietin Beneficial for Anemia Associated with Severe CHF
Journal Watch (General),
July 7, 2000;
2000(707):
4 - 4.
[Full Text]
|
|
|
|
